title: Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor.
authors.affiliation: Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, the Netherlands.
authors.forename: Ferry Alm
authors.initials: FA
authors.lastname: Eskens
authors.affiliation: Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, the Netherlands.
authors.forename: Brigitte
authors.initials: B
authors.lastname: Haberkorn
references.citation: N Engl J Med. 2007 Jan 11;356(2):115-24
references.pmid: 17215529
references.citation: J Clin Oncol. 2012 May 10;30(14):1678-85
references.pmid: 22493422
references.citation: J Clin Oncol. 2013 Oct 20;31(30):3791-9
references.pmid: 24019545
references.citation: J Clin Oncol. 2006 Jun 1;24(16):2505-12
references.pmid: 16636341
references.citation: J Clin Oncol. 2009 Sep 20;27(27):4462-8
references.pmid: 19652060
references.citation: Clin Cancer Res. 2011 Nov 15;17(22):7156-63
references.pmid: 21976547
references.citation: J Clin Oncol. 2010 Jan 20;28(3):475-80
references.pmid: 20008644